AstraZeneca Plc said on Friday it would sell commercial rights for two of its drugs to a German pharmaceutical company for $400 million as the British drugmaker looks to focus on newer medicines in ...
Drugmakers Amgen Inc and AstraZeneca Plc said on Tuesday a pivotal trial found that their experimental medication tezepelumab significantly reduced asthma attacks for people with severe forms of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback